YOUR MEDICATION INFORMATION.
- Published in:
- Brown University Psychopharmacology Update, 2017, v. 28, n. 4, p. 1, doi. 10.1002/pu.30225
- Publication type:
- Article
Works matching IS 10685308 AND DT 2017 AND VI 28 AND IP 4
Results: 8
1
2
ADHD drugs linked to reduced risk of depression in national cohort study.
- Published in:
- Brown University Psychopharmacology Update, 2017, v. 28, n. 4, p. 1, doi. 10.1002/pu.30218
- Publication type:
- Article
3
Pharmacogenomic testing in depression has limited evidence base so far.
- Published in:
- Brown University Psychopharmacology Update, 2017, v. 28, n. 4, p. 1, doi. 10.1002/pu.30219
- Publication type:
- Article
4
Valproate and paliperidone interaction.
- Published in:
- Brown University Psychopharmacology Update, 2017, v. 28, n. 4, p. 2, doi. 10.1002/pu.30220
- By:
- Publication type:
- Article
5
Review highlights poor rates of patient retention in buprenorphine treatment.
- Published in:
- Brown University Psychopharmacology Update, 2017, v. 28, n. 4, p. 3, doi. 10.1002/pu.30221
- Publication type:
- Article
6
Palliative care patients have worsening symptoms of delirium with risperidone, haloperidol.
- Published in:
- Brown University Psychopharmacology Update, 2017, v. 28, n. 4, p. 4, doi. 10.1002/pu.30222
- Publication type:
- Article
7
Research Roundup.
- Published in:
- Brown University Psychopharmacology Update, 2017, v. 28, n. 4, p. 7, doi. 10.1002/pu.30223
- Publication type:
- Article
8
Drug Safety Communication.
- Published in:
- Brown University Psychopharmacology Update, 2017, v. 28, n. 4, p. 8, doi. 10.1002/pu.30224
- Publication type:
- Article